Lee Cowie appointed CEO of accesso® to drive AI strategy
By PR Newswire
May 05, 2026 | 11:53
Lee Cowie has been appointed CEO of accesso®, tasked with accelerating the company's artificial intelligence strategy and technological advancements.
TLX250-Px shows potential in diagnosing diverse kidney cancers
By PR Newswire
May 05, 2026 | 11:50
A new publication highlights the potential of TLX250-Px (Zircaix®) in diagnosing kidney cancers beyond clear cell renal cell carcinoma (ccRCC).
DMALL expands Southeast Asia presence with AI retail platform
By PR Newswire
May 05, 2026 | 11:19
DMALL is gaining momentum in Southeast Asia, leveraging its AI-driven retail platform to enhance operations and market penetration across the region.
Sonilo generates AI music directly from video, no text prompts
By PR Newswire
May 05, 2026 | 11:05
Sonilo has developed a new AI music generation method that eliminates text prompts, creating soundtracks directly from video content.
SPONTAN® Phase II data meets FDA Pre-IND requirements
By PR Newswire
May 05, 2026 | 10:45
Interim Phase II data for SPONTAN® demonstrate rapid onset and a favourable pharmacokinetic profile, addressing FDA Pre-IND requirements across adult and elderly populations.
French May Arts Festival 2026 launches Mona Lisa exhibition
By PR Newswire
May 05, 2026 | 10:28
The French May Arts Festival 2026 has officially launched in Hong Kong, featuring "Meet Mona Lisa & Portraying the Renaissance" as part of The Hong Kong Jockey Club Series.
Edwards' RESILIA tissue shows ten-year durability
By PR Newswire
May 05, 2026 | 10:25
New pivotal data spanning ten years reinforce the long-term durability of Edwards' RESILIA tissue, confirming its sustained performance in medical applications.
Pinecone launches first serverless region in Asia via Singapore
By PR Newswire
May 05, 2026 | 10:14
Pinecone has launched its inaugural serverless cloud region in Asia, establishing a Singapore hub to deliver AI knowledge infrastructure to the Asia-Pacific market.
Cellenkos gains FDA clearance for CK0802 trial in GVHD
By PR Newswire
May 05, 2026 | 10:10
Cellenkos has received FDA clearance for its Investigational New Drug application, enabling a Phase 1b/2a trial of CK0802 for steroid-refractory Graft-versus-Host Disease.
Meiyume achieves EcoVadis gold rating for sustainability
By PR Newswire
May 04, 2026 | 14:40
The beauty manufacturing group secured top-tier recognition from the corporate social responsibility assessment platform.
COSRX sunscreen solidifies Thailand market leadership
By PR Newswire
May 04, 2026 | 14:36
The Korean skincare brand's UV protection product leveraged UK bestseller status and European certification to strengthen Thai market position.
FranklinWH launches enhanced battery in Australia and New Zealand
By PR Newswire
May 04, 2026 | 14:32
The home energy storage manufacturer introduced upgraded 15 kilowatt-hour system to the Oceania markets.
Canton Fair phase 3 features enhanced lifestyle product zones
By PR Newswire
May 04, 2026 | 14:23
The Guangzhou trade show's final session emphasized consumer goods and home products with expanded exhibition categories.
Mobile Version